24HourWire

24HourWire

News from all angles

Financial Times Center

Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn

Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector

Redirecting to Financial Times in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network